{"schema_version":"secwatch.filing_event.v1","accession":"0000012208-23-000041","form_type":"8-K","ticker":"BIO","cik":"0000012208","company_name":"BIO-RAD LABORATORIES, INC.","filed_at":"2023-05-01T23:59:59+00:00","discovered_at":"2026-05-14T18:03:38.186136+00:00","generated_at":"2026-06-16T04:41:48.571509+00:00","sec_items":["5.07"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.15,"confidence":"high","headline":"Bio-Rad annual meeting results: directors elected, say-on-pay approved, political disclosure rejected","bullets":["All 7 director nominees elected; Melinda Litherland and Arnold Pinkston (Class A) each >73% of votes cast.","KPMG ratified as auditor for FY2023 with 7.26M votes for, 19.7K against.","Non-binding advisory vote on executive compensation approved (6.77M for, 277K against).","Advisory frequency set at three years (5.46M votes for three years vs 1.58M for one year).","Stockholder proposal on political disclosure defeated: 5.94M against, 1.10M for."],"urls":{"canonical":"https://secwatch.observer/filing/0000012208-23-000041","json":"https://secwatch.observer/filing/0000012208-23-000041.json","markdown":"https://secwatch.observer/filing/0000012208-23-000041.md","text":"https://secwatch.observer/filing/0000012208-23-000041.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/12208/000001220823000041/0000012208-23-000041-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/12208/000001220823000041/bio-20230425.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-16T04:41:48.571509+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"9d73766b8e462c7bd64a75dfe5c8561ec69bf00e","claim":"BIO-RAD LABORATORIES, INC. shareholders approved Non-binding advisory vote on the frequency of future advisory votes to approve executive compensation at the 2023-04-25 meeting.","evidence_excerpt":"4 With respect to the non-binding advisory vote on the frequency of future advisory votes to approve executive compensation, Three Years received the affirmative vote of a majority of the voting power of the holders of Class A and Class B Common Stock, as follows: Votes Votes Votes Votes Broker 1 Year 2 Years 3 Years Abstaining Non-Votes 1,575,550 14,432 5,461,754 989 225,785","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/12208/000001220823000041/0000012208-23-000041-index.htm","confidence":0.9,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"say on pay frequency"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2023-04-25"}],"fact_type":"shareholder_vote"},{"claim_id":"aadf6093c90a72d7f66bbd51c64fa5517877fc6e","claim":"BIO-RAD LABORATORIES, INC. shareholders rejected Stockholder proposal regarding political disclosure at the 2023-04-25 meeting.","evidence_excerpt":"5. The stockholder proposal regarding political disclosure was not approved since the proposal did not receive the affirmative vote of a majority of the voting power of the holders of Class A and Class B Common Stock, as follows: Votes Votes Votes Broker For Against Abstaining Non-Votes 1,100,154 5,935,081 17,489 225,785","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/12208/000001220823000041/0000012208-23-000041-index.htm","confidence":0.9,"family_label":"Shareholder Votes","details":[{"label":"Outcome","value":"failed"},{"label":"Meeting","value":"2023-04-25"}],"fact_type":"shareholder_vote"},{"claim_id":"c6077c2da479d147d54d0e4319f8f27212274e5d","claim":"BIO-RAD LABORATORIES, INC. shareholders approved Election of Directors at the 2023-04-25 meeting.","evidence_excerpt":"1. Each of the nominated directors was elected and received the affirmative vote of a majority of the votes cast in the respective class of Common Stock, as follows: Class of Common Stock Votes Votes Votes Broker to Elect For Against Abstaining Non-Votes Melinda Litherland Class A 14,950,990 5,818,104 4,785 1,695,304 Arnold A. Pinkston Class A 15,729,846 5,037,217 6,816 1,695,304 Jeffrey L. Edwards Class B 4,974,972 275 90 56,255 Gregory K. Hinckley Class B 4,974,972 275 90 56,255 Allison Schwartz Class B 4,972,669 2,578 90 56,255 Norman Schwartz Class B 4,972,669 2,578 90 56,255","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/12208/000001220823000041/0000012208-23-000041-index.htm","confidence":0.9,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"director election"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2023-04-25"}],"fact_type":"shareholder_vote"},{"claim_id":"e244ef7d362732f2940330b71686acbe3c2d70c1","claim":"BIO-RAD LABORATORIES, INC. shareholders approved Ratification of selection of KPMG LLP as independent auditors at the 2023-04-25 meeting.","evidence_excerpt":"2. The proposal to ratify the selection of KPMG LLP as the Company’s independent auditors for the fiscal year ending December 31, 2023 was ratified and received the affirmative vote of a majority of the voting power of the holders of Class A and Class B Common Stock, as follows: Votes Votes Votes Broker For Against Abstaining Non-Votes 7,258,298 19,666 547 -","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/12208/000001220823000041/0000012208-23-000041-index.htm","confidence":0.9,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"auditor ratification"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2023-04-25"}],"fact_type":"shareholder_vote"},{"claim_id":"ffe2e12839c7805381e38cbdc348b9ac93558de2","claim":"BIO-RAD LABORATORIES, INC. shareholders approved Non-binding advisory vote to approve executive compensation at the 2023-04-25 meeting.","evidence_excerpt":"3. The non-binding advisory vote to approve executive compensation was approved and received the affirmative vote of a majority of the voting power of the holders of Class A and Class B Common Stock, as follows: Votes Votes Votes Broker For Against Abstaining Non-Votes 6,772,070 277,497 3,158 225,785","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/12208/000001220823000041/0000012208-23-000041-index.htm","confidence":0.9,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"say on pay"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2023-04-25"}],"fact_type":"shareholder_vote"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}